We also estimated that oral semaglutide provided patients with +0.23 QALYs and was more cost-effective than lixisenatide, like a study conducted in Sweden proving that semaglutide injection provided greater clinical benefit (+0.71 QALYs) than lixisenatide in patients with poor basal insulin control at a lower cost ( Oral semaglutide demonstrated inferior cost-effectiveness compared to exenatide (ICER: $88,776.61/QALY), possibly due to the latter being the first GLP-1 RA available in the Chinese market, with a lower annual price than other GLP-1 RAs (i.e., semaglutide, dulaglutide, liraglutide, and lixisenatide)
If you qualify and a GLP-1 medication is prescribed, your clinician will help you start at the right dose, monitor your response, and make thoughtful adjustments along the way
Multiple protein feedings ensure amino acids remain available throughout the day
Ozempic, Mounjaro and Wegovy are approved by Health Canada
That structural similarity is the entire point
And thats the only study